Top Anti Cancer Imported Medicine Drugs in India - Pharama Five

Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.

Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Buy Etcamah (Camizestrant) Medicine in India

Etcamah (Camizestrant)

Medicine name : Etcamah

Generic name : Camizestrant

Manufactured By : AstraZeneca

Indications : HR+/HER2- locally advanced or metastatic breast cancer, ESR1-mutated (with a CDK4/6 inhibitor)

Medicine Description : A targeted therapy for HR-positive/HER2-negative locally advanced or metastatic breast cancer, Etcamah (Camizestrant) works by blocking estrogen receptor signaling to help slow the growth of hormone-dependent cancer cells. It is used in patients with ESR1-mutated breast cancer in combination with a CDK4/6 inhibitor. This oral therapy provides a targeted treatment approach for advanced breast cancer.

Product Introduction

Etcamah (Camizestrant) is a targeted anticancer treatment used for adults with hormone receptor-positive (HR-positive), HER2-negative, locally advanced or metastatic breast cancer with an ESR1 mutation. It works by blocking estrogen receptor signaling that can promote the growth and survival of hormone-dependent cancer cells, helping to slow disease progression.

Etcamah (Camizestrant) is used in combination with a CDK4/6 inhibitor as prescribed by your doctor. It is taken orally according to the recommended treatment schedule and should be used consistently throughout treatment. Regular medical check-ups and laboratory tests may be required to monitor treatment response and overall health.

Common side effects of Etcamah (Camizestrant) may include hot flashes, musculoskeletal pain, fatigue, nausea, diarrhea, decreased appetite, headache, and changes in liver function tests. Treatment may also cause changes in heart rhythm or vision in some patients. Inform your doctor promptly if you experience palpitations, fainting, vision changes, severe fatigue, or other concerning symptoms.

Uses Of Etcamah (Camizestrant)

Treatment of ESR1-Mutated Breast Cancer

Benefits Of Etcamah

Etcamah (Camizestrant) is used in combination with a CDK4/6 inhibitor to treat adults with HR-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer. It blocks estrogen receptor signaling that drives hormone-dependent cancer-cell growth, helping to control tumor growth and slow disease progression.

Side Effects Of Etcamah (Camizestrant)

Some side effects of Etcamah (Camizestrant) may improve as the body adjusts to the treatment. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Etcamah (Camizestrant)

  • Hot flashes
  • Musculoskeletal pain
  • Fatigue
  • Nausea
  • Diarrhea
  • Decreased appetite
  • Headache
  • Constipation
  • Increased liver enzymes
  • Changes in blood cell counts
How To Use Etcamah

Take Etcamah (Camizestrant) exactly as prescribed by your doctor, usually once daily. It can be taken with or without food and should be taken at approximately the same time each day. Swallow it whole with water and do not crush, chew, or break it. Etcamah is used in combination with a CDK4/6 inhibitor as directed by your doctor. Follow your doctor's instructions if you miss a dose or vomit after taking it.

How Etcamah (Camizestrant) Works

Etcamah (Camizestrant) is an oral selective estrogen receptor degrader (SERD) that binds to estrogen receptors and promotes their degradation. This reduces estrogen receptor signaling that drives the growth and survival of hormone-dependent breast cancer cells, helping to slow tumor growth and disease progression.

Safety Advice

AlcoholCONSULT YOUR DOCTOR

Limit or avoid alcohol during treatment, as it may worsen side effects such as nausea, fatigue, or dizziness. Follow your doctor's advice.

PregnancyCONSULT YOUR DOCTOR

Etcamah may harm an unborn baby. Women who can become pregnant should use effective contraception during treatment and for the recommended period after the last dose.

BreastfeedingCONSULT YOUR DOCTOR

Do not breastfeed during treatment and for the recommended period after the last dose, as the effects on a breastfed child are not fully known.

DrivingCONSULT YOUR DOCTOR

Avoid driving or operating machinery if you experience dizziness, fatigue, or vision changes that may affect your alertness.

KidneyCAUTION

Inform your doctor if you have kidney problems. Your doctor may monitor kidney function and provide appropriate medical care during treatment.

LiverCAUTION

Tell your doctor about any liver condition. Regular liver function tests may be recommended, and report yellowing of the skin or eyes, dark urine, or unusual tiredness promptly.

Quick Tips
  • Take Etcamah (Camizestrant) exactly as prescribed and follow your doctor's treatment schedule carefully.
  • Take it at approximately the same time each day and follow the prescribed CDK4/6 inhibitor schedule.
  • Report new or worsening vision changes, palpitations, fainting, or unusual dizziness promptly.
  • Inform your doctor if hot flashes, nausea, diarrhea, fatigue, or musculoskeletal pain becomes severe or persistent.
  • Attend regular medical check-ups and laboratory tests to monitor your treatment response and overall health.
  • Read More About - Etcamah (Camizestrant) from Pharma Five.
Faq

General Question

Etcamah (Camizestrant) is an oral targeted therapy used to treat adults with hormone receptor-positive (HR+) and HER2-negative locally advanced or metastatic breast cancer with ESR1 mutations. It is used in combination with a CDK4/6 inhibitor as prescribed by an oncologist.

Etcamah works by targeting and blocking the estrogen receptor, which plays an important role in the growth of hormone receptor-positive breast cancer cells. By reducing estrogen receptor signaling, it helps slow the growth and progression of cancer cells.

Etcamah is intended for adults with HR-positive and HER2-negative locally advanced or metastatic breast cancer whose tumors have an ESR1 mutation. It is used with a CDK4/6 inhibitor under the supervision of an oncologist.

Etcamah is taken orally as prescribed by the treating doctor and is used in combination with a CDK4/6 inhibitor when indicated. Take it exactly according to your prescribed treatment schedule and do not change the dose without medical advice.

Common side effects of Etcamah may include hot flushes, joint pain, fatigue, nausea, headache, decreased appetite, musculoskeletal pain, and other treatment-related symptoms. Your doctor can advise you on managing side effects.

Etcamah may cause serious side effects in some patients. Seek medical attention if you develop severe or persistent symptoms or any unusual reaction during treatment. Your oncologist may perform regular monitoring to identify and manage potential complications.

The duration of Etcamah treatment varies depending on your response to treatment and overall condition. It is generally continued as directed by your oncologist while the treatment is providing benefit and side effects remain manageable. Do not stop treatment without medical advice.

Avoid or limit alcohol while taking Etcamah unless your doctor advises otherwise. Alcohol may worsen certain treatment-related side effects and may make symptoms such as fatigue or dizziness more difficult to manage.

Etcamah may cause harm to an unborn baby and is not recommended during pregnancy unless specifically prescribed by a doctor. Women who can become pregnant should discuss effective contraception with their healthcare provider before and during treatment.

Etcamah may interact with other medicines, including some medicines used to treat cancer and other conditions. Tell your doctor about all prescription medicines, over-the-counter medicines, vitamins, and herbal supplements you are taking before starting treatment.

If you miss a dose of Etcamah, follow your doctor's or pharmacist's instructions. Do not take a double dose to make up for a missed dose. If you are unsure what to do, contact your healthcare provider for advice.

Etcamah can be taken orally with or without food unless your doctor gives you different instructions. Take it consistently according to the prescribed schedule and follow any specific instructions provided with your medicine.

Tell your doctor about your medical history and all medicines you are taking before starting Etcamah. Attend recommended follow-up appointments and monitoring. Report persistent or severe symptoms to your healthcare provider and do not change or stop treatment without medical advice.

Store Etcamah according to the instructions provided on the medicine packaging or by your pharmacist. Keep it in its original container, away from excessive heat and moisture, and out of reach of children. Do not use it after the expiry date.

Etcamah should be obtained through a licensed pharmacy or authorized medicine supplier with a valid prescription from a qualified healthcare professional. Pharma Five assists in its procurement.